|
1
|
Rice TW, Rusch VW, Apperson-Hansen C,
Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE,
et al: Worldwide esophageal cancer collaboration. Dis Esophagus.
22:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thallinger CM, Raderer M and Hejna M:
Esophageal cancer: A critical evaluation of systemic second-line
therapy. J Clin Oncol. 29:4709–4714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar
|
|
4
|
Dalerba P and Clarke MF: Cancer stem cells
and tumor metastasis: First steps into uncharted territory. Cell
Stem Cell. 1:241–242. 2007. View Article : Google Scholar
|
|
5
|
Clarke MF and Fuller M: Stem cells and
cancer: Two faces of eve. Cell. 124:1111–1115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Angelo RC and Wicha MS: Stem cells in
normal development and cancer. Prog mol Biol Transl Sci.
95:113–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roesch A, Fukunaga-Kalabis M, Schmidt EC,
Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T
and Herlyn M: A temporarily distinct subpopulation of slow-cycling
melanoma cells is required for continuous tumor growth. Cell.
141:583–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pece S, Tosoni D, Confalonieri S, Mazzarol
G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG and Di Fiore
PP: Biological and molecular heterogeneity of breast cancers
correlates with their cancer stem cell content. Cell. 140:62–73.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dembinski JL and Krauss S:
Characterization and functional analysis of a slow cycling stem
cell-like subpopulation in pancreas adenocarcinoma. Clin Exp
Metastasis. 26:611–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen W, Dong J, Haiech J, Kilhoffer MC and
Zeniou M: Cancer stem cell quiescence and plasticity as major
challenges in cancer therapy. Stem Cells Int. 2016:17409362016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adorno-Cruz V, Kibria G, Liu X, Doherty M,
Junk DJ, Guan D, Hubert C, Venere M, Mulkearns-Hubert E, Sinyuk M,
et al: Cancer stem cells: Targeting the roots of cancer, seeds of
metastasis, and sources of therapy resistance. Cancer Res.
75:924–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L and Bhatia R: Stem cell quiescence.
Clin Cancer Res. 17:4936–4941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okumura T, Tsunoda S, Mori Y, Ito T,
Kikuchi K, Wang TC, Yasumoto S and Shimada Y: The biological role
of the low-affinity p75 neurotrophin receptor in esophageal
squamous cell carcinoma. Clin Cancer Res. 12:5096–5103. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG,
Wang F, Luo JH and Xu ZY: Self-renewal and chemotherapy resistance
of p75NTR positive cells in esophageal squamous cell carcinomas.
BMC Cancer. 9:92009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Yue D, Chen X, Wang L, Li J, Ping Y,
Gao Q, Wang D,, Zhang T, Li F, et al: Epigenetic regulation of
CD271, a potential cancer stem cell marker associated with
chemoresistance and metastatic capacity. Oncol Rep. 33:425–432.
2015.
|
|
18
|
Yamaguchi T, Okumura T, Hirano K, Watanabe
T, Nagata T, Shimada Y and Tsukada K: p75 neurotrophin receptor
expression is a characteristic of the mitotically quiescent cancer
stem cell population present in esophageal squamous cell carcinoma.
Int J Oncol. 48:1943–1954. 2016.PubMed/NCBI
|
|
19
|
Okumura T, Shimada Y, Imamura M and
Yasumoto S: Neurotrophin receptor p75 (NTR) characterizes human
esophageal keratinocyte stem cells in vitro. Oncogene.
22:4017–4026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okumura T, Shimada Y, Sakurai T, Hori R,
Nagata T, Sakai Y and Tsukada K: Abnormal cell proliferation in the
p75NTR-positive basal cell compartment of the esophageal epithelium
during squamous carcinogenesis. Dis Esophagus. 28:634–643. 2015.
View Article : Google Scholar
|
|
21
|
Shimada Y, Imamura M, Wagata T, Yamaguchi
N and Tobe T: Characterization of 21 newly established esophageal
cancer cell lines. Cancer. 69:277–284. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bradford JA and Clarke ST: Dual-pulse
labeling using 5-ethynyl-2′-deoxyuridine (Edu) and
5-bromo-2′-deoxyuridine (Brdu) in flow cytometry. Curr Protoc
Cytom. 55:7.38.1–7.38.15. 2011.
|
|
25
|
Hsu YC and Fuchs E: A family business:
Stem cell progeny join the niche to regulate homeostasis. Nat Rev
Mol Cell Biol. 13:103–114. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hadjimichael C, Chanoumidou K,
Papadopoulou N, Arampatzi P, Papamatheakis J and Kretsovali A:
Common stemness regulators of embryonic and cancer stem cells.
World J Stem Cells. 7:1150–1184. 2015.PubMed/NCBI
|
|
27
|
Oren O and Smith BD: Eliminating cancer
stem cells by targeting embryonic signaling pathways. Stem Cell
Rev. 13:17–23. 2017. View Article : Google Scholar
|
|
28
|
Yu X, Jiang X, Li H, Guo L, Jiang W and Lu
SH: miR-203 inhibits the proliferation and self-renewal of
esophageal cancer stem-like cells by suppressing stem renewal
factor Bmi-1. Stem Cells Dev. 23:576–585. 2014. View Article : Google Scholar
|
|
29
|
Lee KB, Ye S, Park MH, Park BH, Lee JS and
Kim SM: p63-Mediated activation of the β-catenin/c-Myc signaling
pathway stimulates esophageal squamous carcinoma cell invasion and
metastasis. Cancer Lett. 353:124–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye S, Lee KB, Park MH, Lee JS and Kim SM:
p63 regulates growth of esophageal squamous carcinoma cells via the
Akt signaling pathway. Int J Oncol. 44:2153–2159. 2014.PubMed/NCBI
|
|
31
|
Tomellini E, Touil Y, Lagadec C, Julien S,
Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E,
Polakowska R, et al: Nerve growth factor and proNGF simultaneously
promote symmetric self-renewal, quiescence, and epithelial to
mesenchymal transition to enlarge the breast cancer stem cell
compartment. Stem Cells. 33:342–353. 2015. View Article : Google Scholar
|
|
32
|
Tsunoda S, Okumura T, Ito T, Mori Y, Soma
T, Watanabe G, Kaganoi J, Itami A, Sakai Y and Shimada Y:
Significance of nerve growth factor overexpression and its
autocrine loop in oesophageal squamous cell carcinoma. Br J Cancer.
95:322–330. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al CROSS Group:
Preoperative chemoradiotherapy for esophageal or junctional cancer.
N Engl J Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan L, Yu WM, Yuan Z, Haudenschild CC and
Qu CK: Role of ShP-2 tyrosine phosphatase in the DNA damage-induced
cell death response. J Biol Chem. 278:15208–15216. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Galluzzi L, Senovilla L, Zitvogel L and
Kroemer G: The secret ally: Immunostimulation by anticancer drugs.
Nat Rev Drug Discov. 11:215–233. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsunoda S, Okumura T, Ito T, Kondo K,
Ortiz C, Tanaka E, Watanabe G, Itami A, Sakai Y and Shimada Y:
ABCG2 expression is an independent unfavorable prognostic factor in
esophageal squamous cell carcinoma. Oncology. 71:251–258. 2006.
View Article : Google Scholar
|
|
37
|
Furuta T, Ueda T, Aune G, Sarasin A,
Kraemer KH and Pommier Y: Transcription-coupled nucleotide excision
repair as a determinant of cisplatin sensitivity of human cells.
Cancer Res. 62:4899–4902. 2002.PubMed/NCBI
|
|
38
|
Huang J, Zhou Y, Zhang H, Qu T, Mao Y, Zhu
H, Quan L, Xing P, Wang J, He J, et al: A phase II study of
biweekly paclitaxel and cisplatin chemotherapy for recurrent or
metastatic esophageal squamous cell carcinoma: ERCC1 expression
predicts response to chemotherapy. Med Oncol. 30:3432013.
View Article : Google Scholar
|
|
39
|
Chen WH, Xin PL, Pan QX, Chen YY, Wang CR,
Zhang ZS, Chen YF, Zhang CY and Cai WJ: ERCC1 single nucleotide
polymorphism C8092A, but not its expression is associated with
survival of esophageal squamous cell carcinoma patients from Fujian
province, China. PLoS One. 9:e1066002014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu X, Xiao H, Zhao B, Zhang X and Wang G:
DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of
recurrent esophageal cancer to radiochemotherapy in a Chinese
population. Thorac Cancer. 6:741–748. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang L, Zhang X, Zhang M, Zhang J, Sheng
Y, Sun X, Chen Q and Wang LX: Increased Nanog expression promotes
tumor development and Cisplatin resistance in human esophageal
cancer cells. Cell Physiol Biochem. 30:943–952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yin T, Wei H, Leng Z, Yang Z, Gou S, Wu H,
Zhao G, Hu X and Wang C: Bmi-1 promotes the chemoresistance,
invasion and tumorigenesis of pancreatic cancer cells.
Chemotherapy. 57:488–496. 2011. View Article : Google Scholar
|
|
43
|
Banerjee Mustafi S, Chakraborty PK, Naz S,
Dwivedi SK, Street M, Basak R, Yang D, Ding K, Mukherjee P and
Bhattacharya R: MDR1 mediated chemoresistance: BMI1 and TIP60 in
action. Biochim Biophys Acta. 1859:983–993. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao JS, Li WJ, Ge D, Zhang PJ, Li JJ, Lu
CL, Ji XD, Guan DX, Gao H, Xu LY, et al: Tumor initiating cells in
esophageal squamous cell carcinomas express high levels of CD44.
PLoS One. 6:e214192011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tang KH, Dai YD, Tong M, Chan YP, Kwan PS,
Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, et al: A CD90+
tumor-initiating cell population with an aggressive signature and
metastatic capacity in esophageal cancer. Cancer Res. 73:2322–2332.
2013. View Article : Google Scholar : PubMed/NCBI
|
